2026.08.03 기준 · 총 81종목
칸의 넓이가 비중에 비례합니다. 상위 31칸만 그리며, 전체 수치는 아래 표에 있습니다.
비중은 현금성 자산과 선물을 제외한 평가금액 기준입니다. 선물 행은 비중을 표기하지 않습니다. 설정현금액·원화현금 등 현금성 자산은 목록에서 제외했습니다 — 종목이 아니고, 정산 과정에서 음수로 잡히기도 합니다.
| 순위 | 종목명 | 종목코드 | 비중 | 평가금액 | 1CU당 수량 | 시장 |
|---|---|---|---|---|---|---|
| 1 | AMGEN INC | AMGN | 10.17% | 55,382,095 | 100.33 | 해외(나스닥) |
| 2 | Vertex Pharmaceuticals Inc | VRTX | 9.63% | 52,433,314 | 76.44 | 해외(나스닥) |
| 3 | GILEAD SCIENCES INC | GILD | 9.42% | 51,274,649 | 274.28 | 해외(나스닥) |
| 4 | Revolution Medicines Inc | RVMD | 3.59% | 19,565,980 | 71.50 | 해외(나스닥) |
| 5 | Natera Inc | NTRA | 3.42% | 18,600,758 | 48.44 | 해외(나스닥) |
| 6 | BeOne Medicines Ltd | ONC | 3.29% | 17,887,034 | 39.00 | 해외(나스닥) |
| 7 | BIOGEN | BIIB | 3.10% | 16,877,262 | 57.00 | 해외(나스닥) |
| 8 | Argenx SE | ARGX | 2.83% | 15,395,243 | 12.39 | 해외(나스닥) |
| 9 | INCYTE CORP | INCY | 2.43% | 13,222,900 | 75.50 | 해외(나스닥) |
| 10 | BioNTech SE | BNTX | 2.27% | 12,376,964 | 93.61 | 해외(나스닥) |
| 11 | MODERNA INC | MRNA | 2.24% | 12,206,755 | 148.00 | 해외(나스닥) |
| 12 | Guardant Health Inc | GH | 2.02% | 10,979,657 | 50.61 | 해외(나스닥) |
| 13 | NEUROCRINE BIOSCIENCES INC | NBIX | 1.85% | 10,053,625 | 38.06 | 해외(나스닥) |
| 14 | ALNYLAM PHARMACEUTICALS INC | ALNY | 1.72% | 9,363,312 | 32.00 | 해외(나스닥) |
| 15 | Genmab A/S | GMAB | 1.69% | 9,212,553 | 225.89 | 해외(나스닥) |
| 16 | JAZZ PHARMACEUTICALS PLC | JAZZ | 1.69% | 9,176,252 | 24.94 | 해외(나스닥) |
| 17 | Bridgebio Pharma Inc | BBIO | 1.64% | 8,909,403 | 76.17 | 해외(나스닥) |
| 18 | Ascendis Pharma A/S | ASND | 1.58% | 8,619,895 | 24.11 | 해외(나스닥) |
| 19 | Exelixis Inc | EXEL | 1.49% | 8,111,996 | 101.78 | 해외(나스닥) |
| 20 | Arrowhead Pharmaceuticals Inc | ARWR | 1.28% | 6,963,246 | 56.00 | 해외(나스닥) |
| 21 | Corcept Therapeutics Inc | CORT | 1.27% | 6,907,994 | 41.00 | 해외(나스닥) |
| 22 | BIOMARIN PHARMACEUTICAL INC | BMRN | 1.20% | 6,546,720 | 75.89 | 해외(나스닥) |
| 23 | Madrigal Pharmaceuticals Inc | MDGL | 1.18% | 6,439,069 | 9.17 | 해외(나스닥) |
| 24 | Axsome Therapeutics Inc | AXSM | 1.15% | 6,238,157 | 18.67 | 해외(나스닥) |
| 25 | Summit Therapeutics Inc | SMMT | 1.13% | 6,171,037 | 322.44 | 해외(나스닥) |
| 26 | Krystal Biotech Inc | KRYS | 1.08% | 5,892,608 | 11.28 | 해외(나스닥) |
| 27 | Protagonist Therapeutics Inc | PTGX | 0.90% | 4,880,305 | 24.72 | 해외(나스닥) |
| 28 | Praxis Precision Medicines Inc | PRAX | 0.89% | 4,846,890 | 11.06 | 해외(나스닥) |
| 29 | ALKERMES PLC | ALKS | 0.87% | 4,733,366 | 66.44 | 해외(나스닥) |
| 30 | Kymera Therapeutics Inc | KYMR | 0.86% | 4,707,087 | 30.89 | 해외(나스닥) |
| 31 | Dianthus Therapeutics Inc | DNTH | 0.85% | 4,651,581 | 29.00 | 해외(나스닥) |
| 32 | Cogent Biosciences Inc | COGT | 0.84% | 4,593,937 | 78.00 | 해외(나스닥) |
| 33 | Oruka Therapeutics Inc | ORKA | 0.79% | 4,319,931 | 31.00 | 해외(나스닥) |
| 34 | Tempus AI Inc | TEM | 0.78% | 4,257,154 | 67.50 | 해외(나스닥) |
| 35 | ImmunityBio Inc | IBRX | 0.74% | 4,001,321 | 377.17 | 해외(나스닥) |
| 36 | Mirum Pharmaceuticals Inc | MIRM | 0.73% | 3,990,567 | 24.89 | 해외(나스닥) |
| 37 | Rhythm Pharmaceuticals Inc | RYTM | 0.73% | 3,990,204 | 26.50 | 해외(나스닥) |
| 38 | Halozyme Therapeutics Inc | HALO | 0.71% | 3,842,075 | 32.39 | 해외(나스닥) |
| 39 | Erasca Inc | ERAS | 0.68% | 3,725,640 | 140.06 | 해외(나스닥) |
| 40 | PTC Therapeutics Inc | PTCT | 0.64% | 3,506,895 | 32.61 | 해외(나스닥) |
| 41 | Scholar Rock Holding Corp | SRRK | 0.64% | 3,488,088 | 50.00 | 해외(나스닥) |
| 42 | Definium Therapeutics Inc | DFTX | 0.63% | 3,421,103 | 54.00 | 해외(나스닥) |
| 43 | Edgewise Therapeutics Inc | EWTX | 0.59% | 3,184,799 | 54.39 | 해외(나스닥) |
| 44 | Billiontoone Inc | BLLN | 0.56% | 3,025,373 | 15.22 | 해외(나스닥) |
| 45 | Dyne Therapeutics Inc | DYN | 0.55% | 2,986,120 | 81.50 | 해외(나스닥) |
| 46 | Xenon Pharmaceuticals Inc | XENE | 0.50% | 2,742,196 | 30.00 | 해외(나스닥) |
| 47 | Veracyte Inc | VCYT | 0.47% | 2,548,693 | 29.94 | 해외(나스닥) |
| 48 | Legend Biotech Corp | LEGN | 0.46% | 2,495,702 | 92.00 | 해외(나스닥) |
| 49 | Caris Life Sciences Inc | CAI | 0.46% | 2,494,905 | 108.89 | 해외(나스닥) |
| 50 | Arcutis Biotherapeutics Inc | ARQT | 0.46% | 2,477,956 | 62.17 | 해외(나스닥) |
| 51 | Relay Therapeutics Inc | RLAY | 0.44% | 2,409,621 | 87.00 | 해외(나스닥) |
| 52 | Viking Therapeutics Inc | VKTX | 0.44% | 2,404,580 | 51.00 | 해외(나스닥) |
| 53 | CRISPR Therapeutics AG | CRSP | 0.44% | 2,391,486 | 34.67 | 해외(나스닥) |
| 54 | Denali Therapeutics Inc | DNLI | 0.44% | 2,388,719 | 68.89 | 해외(나스닥) |
| 55 | Ideaya Biosciences Inc | IDYA | 0.42% | 2,306,595 | 44.50 | 해외(나스닥) |
| 56 | Enliven Therapeutics Inc | ELVN | 0.42% | 2,304,744 | 30.00 | 해외(나스닥) |
| 57 | ACADIA Pharmaceuticals Inc | ACAD | 0.41% | 2,230,624 | 59.00 | 해외(나스닥) |
| 58 | Immunome Inc | IMNM | 0.39% | 2,149,102 | 65.39 | 해외(나스닥) |
| 59 | Arcus Biosciences Inc | RCUS | 0.39% | 2,125,245 | 52.83 | 해외(뉴욕) |
| 60 | Adaptive Biotechnologies Corp | ADPT | 0.38% | 2,089,008 | 60.67 | 해외(나스닥) |
| 61 | Structure Therapeutics Inc | GPCR | 0.37% | 2,023,188 | 28.72 | 해외(나스닥) |
| 62 | Newamsterdam Pharma Co NV | NAMS | 0.34% | 1,841,548 | 45.44 | 해외(나스닥) |
| 63 | BioCryst Pharmaceuticals Inc | BCRX | 0.32% | 1,763,139 | 134.00 | 해외(나스닥) |
| 64 | Disc Medicine Inc | IRON | 0.32% | 1,741,555 | 15.44 | 해외(나스닥) |
| 65 | Compass Therapeutics Inc | CMPX | 0.30% | 1,653,392 | 598.50 | 해외(나스닥) |
| 66 | GRAIL Inc | GRAL | 0.29% | 1,592,488 | 15.72 | 해외(나스닥) |
| 67 | Ultragenyx Pharmaceutical Inc | RARE | 0.27% | 1,491,396 | 40.22 | 해외(나스닥) |
| 68 | Beam Therapeutics Inc | BEAM | 0.26% | 1,439,839 | 38.17 | 해외(나스닥) |
| 69 | Zai Lab Ltd | ZLAB | 0.25% | 1,378,753 | 53.17 | 해외(나스닥) |
| 70 | Tarsus Pharmaceuticals Inc | TARS | 0.25% | 1,361,646 | 16.06 | 해외(나스닥) |
| 71 | CG oncology Inc | CGON | 0.25% | 1,340,491 | 12.89 | 해외(나스닥) |
| 72 | Agios Pharmaceuticals Inc | AGIO | 0.24% | 1,305,808 | 28.00 | 해외(나스닥) |
| 73 | Ligand Pharmaceuticals Inc | LGND | 0.23% | 1,265,750 | 3.00 | 해외(나스닥) |
| 74 | HeartFlow Inc | HTFL | 0.23% | 1,250,585 | 34.00 | 해외(나스닥) |
| 75 | Sionna Therapeutics Inc | SION | 0.21% | 1,132,450 | 17.00 | 해외(나스닥) |
| 76 | LivaNova PLC | LIVN | 0.20% | 1,089,519 | 9.44 | 해외(나스닥) |
| 77 | Stoke Therapeutics Inc | STOK | 0.17% | 941,093 | 22.00 | 해외(나스닥) |
| 78 | Zymeworks Inc | ZYME | 0.17% | 937,832 | 29.00 | 해외(나스닥) |
| 79 | SAREPTA THERAPEUTICS INC | SRPT | 0.17% | 908,455 | 41.00 | 해외(나스닥) |
| 80 | IRhythm Holdings Inc | IRTC | 0.14% | 752,890 | 4.44 | 해외(나스닥) |
| 81 | ADMA Biologics Inc | ADMA | 0.11% | 590,513 | 47.83 | 해외(나스닥) |